Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Trial Profile

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2010

At a glance

  • Drugs Esomeprazole/naproxen; Naproxen
  • Indications Musculoskeletal pain; Rheumatic disorders
  • Focus Pharmacokinetics
  • Sponsors POZEN
  • Most Recent Events

    • 29 Jan 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top